APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development

Cell Reports

Volumn 7, Issue 6, 2014, Pages 1833-1841

  Henderson, Stephen ^a   Chakravarthy, Ankur ^a   Su, Xiaoping ^b   Boshoff, Chris ^a,c   Fenton, Tim Robert ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE LIKE FAMILY; HYDROLASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; UNCLASSIFIED DRUG; APOBEC3B PROTEIN, HUMAN; CYTIDINE DEAMINASE; CYTOSINE; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN;

ARTICLE; DEAMINATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE SEQUENCE; MUTAGENESIS; NONHUMAN; PIK3CA GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SMOKING; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; WART VIRUS; ENZYMOLOGY; GENETICS; HEAD AND NECK TUMOR; HUMAN; METABOLISM; MUTATION; PAPILLOMAVIRIDAE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, VIRAL; CYTIDINE DEAMINASE; CYTOSINE; DEAMINATION; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; PAPILLOMAVIRIDAE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN STRUCTURE, TERTIARY;

EID: 84903390239     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.012     Document Type: Article

References (44)

1. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., Li R.J., Fakhry C., Xie T.-X., Zhang J., Wang J., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
2. Alexandrov L.B., Nik-Zainal S., Wedge D.C., Aparicio S.A.J.R., Behjati S., Biankin A.V., Bignell G.R., Bolli N., Borg A., Børresen-Dale A.-L., et al. Signatures of mutational processes in human cancer. Nature 2013, 500:415-421. Australian Pancreatic Cancer Genome Initiative, ICGC Breast Cancer ConsortiumICGC Breast Cancer Consortium, ICGC MMML-Seq ConsortiumICGC MMML-Seq Consortium, ICGC PedBrainICGC PedBrain.
3. Alexandrov L.B., Nik-Zainal S., Wedge D.C., Campbell P.J., Stratton M.R. Deciphering signatures of mutational processes operative in human cancer. Cell Reports 2013, 3:246-259.
4. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.-J., Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 2004, 14:1392-1396.
5. Broad Institute TCGA Genome Data Analysis Center B.-T.-G. (2013). Mutation Analysis (MutSigCV v0.9). http://gdac.broadinstitute.org/runs/analyses__2013_05_23/reports/cancer/HNSC/MutSigNozzleReportCV/nozzle.html.
6. Burns M.B., Lackey L., Carpenter M.A., Rathore A., Land A.M., Leonard B., Refsland E.W., Kotandeniya D., Tretyakova N., Nikas J.B., et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 2013, 494:366-370.
7. Burns M.B., Temiz N.A., Harris R.S. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. 2013, 45:977-983.
8. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
9. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., Jiang B., Goodman M.T., Sibug-Saber M., Cozen W., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J.Clin. Oncol. 2011, 29:4294-4301.
10. Chen Y., Yao H., Thompson E.J., Tannir N.M., Weinstein J.N., Su X. VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue. Bioinformatics 2013, 29:266-267.
11. Conticello S.G. The AID/APOBEC family of nucleic acid mutators. Genome Biol. 2008, 9:229.
12. Drier Y., Lawrence M.S., Carter S.L., Stewart C., Gabriel S.B., Lander E.S., Meyerson M., Beroukhim R., Getz G. Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res. 2013, 23:228-235.
13. Goon P.K., Stanley M.A., Ebmeyer J., Steinsträsser L., Upile T., Jerjes W., Bernal-Sprekelsen M., Görner M., Sudhoff H.H. HPV & head and neck cancer: a descriptive update. Head Neck Oncol. 2009, 1:36.
14. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113:803-809.
15. Kuong K.J., Loeb L.A. APOBEC3B mutagenesis in cancer. Nat. Genet. 2013, 45:964-965.
16. Lawrence M.S., Stojanov P., Polak P., Kryukov G.V., Cibulskis K., Sivachenko A., Carter S.L., Stewart C., Mermel C.H., Roberts S.A., et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013, 499:214-218.
17. Lechner M., Fenton T., West J., Wilson G., Feber A., Henderson S., Thirlwell C., Dibra H.K., Jay A., Butcher L., et al. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med. 2013, 5:15.
18. Lechner M., Frampton G.M., Fenton T., Feber A., Palmer G., Jay A., Pillay N., Forster M., Cronin M.T., Lipson D., et al. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Med. 2013, 5:49.
19. Leonard B., Hart S.N., Burns M.B., Carpenter M.A., Temiz N.A., Rathore A., Vogel R.I., Nikas J.B., Law E.K., Brown W.L., et al. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Res. 2013, 73:7222-7231.
20. Lui V.W.Y., Hedberg M.L., Li H., Vangara B.S., Pendleton K., Zeng Y., Lu Y., Zhang Q., Du Y., Gilbert B.R., et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013, 3:761-769.
21. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
22. Matsumoto Y., Marusawa H., Kinoshita K., Endo Y., Kou T., Morisawa T., Azuma T., Okazaki I.-M., Honjo T., Chiba T. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 2007, 13:470-476.
23. McLaughlin-Drubin M.E., Münger K. Oncogenic activities of human papillomaviruses. Virus Res. 2009, 143:195-208.
24. Nik-Zainal S., Alexandrov L.B., Wedge D.C., Van Loo P., Greenman C.D., Raine K., Jones D., Hinton J., Marshall J., Stebbings L.A., et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993. Breast Cancer Working Group of the International Cancer Genome Consortium.
25. Ojesina A.I., Lichtenstein L., Freeman S.S., Pedamallu C.S., Imaz-Rosshandler I., Pugh T.J., Cherniack A.D., Ambrogio L., Cibulskis K., Bertelsen B., et al. Landscape of genomic alterations in cervical carcinomas. Nature 2014, 506:371-375.
26. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K., Honjo T. Constitutive expression of AID leads to tumorigenesis. J.Exp. Med. 2003, 197:1173-1181.
27. Parker J.S., Mullins M., Cheang M.C.U., Leung S., Voduc D., Vickery T., Davies S., Fauron C., He X., Hu Z., et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J.Clin. Oncol. 2009, 27:1160-1167.
28. Pfeifer G.P., You Y.-H., Besaratinia A. Mutations induced by ultraviolet light. Mutat. Res. 2005, 571:19-31.
29. Pham P., Bransteitter R., Goodman M.F. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry 2005, 44:2703-2715.
30. Psyrri A., DiMaio D. Human papillomavirus in cervical and head-and-neck cancer. Nat. Clin. Pract. Oncol. 2008, 5:24-31.
31. Ramqvist T., Dalianis T. Oropharyngeal cancer epidemic and human papillomavirus. Emerg. Infect. Dis. 2010, 16:1671-1677.
32. Roberts S.A., Gordenin D.A. Clustered and genome-wide transient mutagenesis in human cancers: Hypermutation without permanent mutators or loss of fitness. BioEssays 2014, Published online February 26, 2014. 10.1002/bies.201300140.
33. Roberts S.A., Sterling J., Thompson C., Harris S., Mav D., Shah R., Klimczak L.J., Kryukov G.V., Malc E., Mieczkowski P.A., et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 2012, 46:424-435.
34. Roberts S.A., Lawrence M.S., Klimczak L.J., Grimm S.A., Fargo D., Stojanov P., Kiezun A., Kryukov G.V., Carter S.L., Saksena G., et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 2013, 45:970-976.
35. Simonelli V., Narciso L., Dogliotti E., Fortini P. Base excision repair intermediates are mutagenic in mammalian cells. Nucleic Acids Res. 2005, 33:4404-4411.
36. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., Kryukov G.V., Lawrence M.S., Sougnez C., McKenna A., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
37. Tang K.W., Alaei-Mahabadi B., Samuelsson T., Lindh M., Larsson E. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat. Commun. 2013, 4:2513.
38. Vartanian J.-P., Guétard D., Henry M., Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008, 320:230-233.
39. Vartanian J.-P., Henry M., Marchio A., Suspène R., Aynaud M.-M., Guétard D., Cervantes-Gonzalez M., Battiston C., Mazzaferro V., Pineau P., et al. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog. 2010, 6:e1000928.
40. Vogt P.K., Kang S., Elsliger M.-A., Gymnopoulos M. Cancer-specific mutations in phosphatidylinositol 3-kinase. Trends Biochem. Sci. 2007, 32:342-349.
41. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J.F., Peto J., Meijer C.J.L.M., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J.Pathol. 1999, 189:12-19.
42. Yamanaka S., Balestra M.E., Ferrell L.D., Fan J., Arnold K.S., Taylor S., Taylor J.M., Innerarity T.L. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA 1995, 92:8483-8487.
43. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98.
44. Zhao L., Vogt P.K. Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain offunction by different mechanisms. Proc. Natl. Acad. Sci. USA 2008, 105:2652-2657.